Zymeworks Inc share price logo

Zymeworks Inc Share Price

NYSE: ZYME

Small Cap

$16.02

+0.09

(+0.56%)

Live

as on

Zymeworks Inc Stock Performance

as on September 16, 2025 at 7:42 pm IST

  • Day's Low

    Day's High

    $15.8
    $16.12
    downward going graph

    1.37%

    Downside

    0.62%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.03
    $17.7
    downward going graph

    43.63%

    Downside

    10.49%

    Upside

    downward going graph

Zymeworks Inc share price movements today

Previous Close
$15.93
Open
$15.93
Volume
37.5K
Day's Low - High
$15.8 - $16.12
52 Week Low - High
$9.03 - $17.7

Zymeworks Inc Historical Returns

1 Month Return
+ 10.93 %
3 Month Return
+ 25.93 %
1 Year Return
+ 27.34 %
3 Year Return
+ 181.45 %
5 Year Return
0 %

Zymeworks Inc Stock Fundamentals & Key Indicators

Check Zymeworks Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-0.7826

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.51

Industry PE ratio

-0.49107142857142855

P/B Ratio

0

PEG Ratio

0

EBITDA

-72.6M

Revenue (TTM)

122.9M

Profit Margin

-59.96%

Return On Equity TTM

41853100.00%

Zymeworks Inc Stock Valuation

Track how Zymeworks Inc P/E has moved over time to understand its valuation trends.

Zymeworks Inc in the last 5 years

  • Overview

  • Trends

Lowest (2.37x)

September 30, 2023

Today (-3.51x)

September 16, 2025

Industry (-0.49x)

September 16, 2025

Highest (3.97x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.51x

Zymeworks Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zymeworks Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.2BNA-3.51-59.96%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Zymeworks Inc Stock including INR - Dollar returns

The Zymeworks Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Zymeworks Inc investment value today

Current value as on today

₹1,32,925

Returns

₹32,925

(+32.93%)

Returns from Zymeworks Inc Stock

₹28,058 (+28.06%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Zymeworks Inc Stock

Based on 14 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Zymeworks Inc. Average target price of $21.05

Zymeworks Inc Share Price Target

Get share price movements and forecasts by analysts on Zymeworks Inc.

What analysts predicted

23.9%UPSIDE

Target Price

$21.05

Current Price

$16.02

Analyzed by

14 Analysts

Target

$21.05

Zymeworks Inc target price $21.05, a slight upside of 23.9% compared to current price of $16.02. According to 14 analysts rating.

Zymeworks Inc Stock's Interest Amongst Investors

Search interest for Zymeworks Inc Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-40% versus previous 30 day period

Zymeworks Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
35
7
16
16
10
19
16
31
27
48
Gross Profit
-9
-32
-16
-8
-22
16
13
27
27
48
Operating Income
-27
-54
-33
-23
-37
-25
-34
-22
-25
0
EBITDA
-24
-49
-21
-21
-36
-23
-26
-14
-22
2
Interest Expense
7
-
-
7
-
-
-
-
-
-
Depreciation
2
4
6
3
2
2
2
3
3
3
Income Before Tax
-22
-49
-27
-19
-31
-37
-29
-17
-22
2
Income Tax Expense
1
1
-1
-4
0
0
0
5
0
0
Net Income
-24
-51
-28
-14
-31
-37
-29
-23
-22
2
Net Profit Margin
-68.45%
-730.53%
-173.80%
-85.56%
-315.58%
-195.84%
-186.56%
-75.75%
-83.50%
4.76%

Zymeworks Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
9
11
51
53
29
38
26
412
76
76
Gross Profit
-14
-24
10
53
-87
38
26
412
-66
65
Operating Income
-19
-37
-8
-33
-151
-187
-215
130
-138
-119
EBITDA
-18
-36
-6
-29
-143
-177
-206
142
-120
-105
Interest Expense
0
0
1
0
11
17
12
3
-
-
Depreciation
-
-
2
3
7
10
12
12
17
11
Income Before Tax
-19
-38
-9
-34
-146
-180
-212
135
-119
-116
Income Tax Expense
0
-5
0
2
0
0
0
10
0
6
Net Income
-19
-33
-10
-36
-145
-180
-211
124
-118
-122
Net Profit Margin
-198.45%
-307.10%
-20.10%
-68.95%
-492.27%
-463.54%
-794.01%
30.14%
-156.13%
-160.80%

Zymeworks Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-51
-28
-14
-31
-37
-29
-23
-22
2
Operating Cash Flow
-6
-42
13
-37
-24
-5
-41
-3
12
Investing Cash Flow
-60
-7
-1
-7
-19
72
-6
12
8
Financing Cash Flow
27
1
50
2
1
-14
-8
1
1
Change in Cash
-39
-47
63
-42
-43
51
-56
10
22

Zymeworks Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-33
-10
-36
-145
-180
-211
124
-118
-122
Operating Cash Flow
-35
0
24
-81
-151
-192
144
-118
-110
Investing Cash Flow
-25
-30
-109
-25
-43
144
-53
-207
38
Financing Cash Flow
64
49
91
193
308
8
108
81
-20
Change in Cash
4
19
6
86
113
-40
199
-243
-91

Global Institutional Holdings in Zymeworks Inc

Funds
Holdings
EcoR1 Capital, LLC
22.89%
Redmile Group, LLC
6.35%
Rubric Capital Management LP
5.75%
Bvf Inc
5.71%
BlackRock Inc
5.42%

Insights on Zymeworks Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 27.11M → 48.72M (in $), with an average increase of 44.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -37.68M → 2.31M (in $), with an average increase of 283.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ZYME has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, ZYME stock has moved up by 181.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 43.3%

About Zymeworks Inc

zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company’s novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics targeted across a range of indications. zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. more information on zymeworks can be found at www.zymeworks.com.
OrganisationZymeworks Inc
Headquarters108 Patriot Drive, Middletown, DE, United States, 19709
IndustryHealth Technology
CEOMr. Kenneth H. Galbraith C.A.
E-voting on sharesClick here to vote

Key Management of Zymeworks Inc

Name

Title

Ms. Leone D. Patterson CPA, M.B.A.

Executive VP and Chief Business & Financial Officer

Dr. Paul A. Moore Ph.D.

Chief Scientific Officer

Mr. Mark Hollywood

Executive VP and Head of Technical & Manufacturing Operations

Mr. Daniel Dex J.D., Ph.D.

Senior VP, Corporate Secretary & General Counsel

Ms. Laura O'Connor

Vice President of Human Resources & DEI

Mr. Kenneth H. Galbraith C.A.

Chairman of the Board, CEO & President

Ms. Shrinal Inamdar

Director of Investor Relations

Diana Papove

Senior Manager of Corporate Communications

Dr. Lindsey Foulkes B.Sc., Ph.D.

Vice President of Corporate Development

Dr. Jeffrey Smith M.D.

Executive VP & Chief Medical Officer

FAQs

What is Zymeworks Inc share price today?

Zymeworks Inc share price today is $16.02 as on . Zymeworks Inc share today touched a day high of $16.12 and a low of $15.8.

What is the 52 week high and 52 week low for Zymeworks Inc share?

Zymeworks Inc share touched a 52 week high of $17.7 on and a 52 week low of $9.03 on . Zymeworks Inc stock price today i.e. is trending at $16.02,which is 9.49% down from its 52 week high and 77.41% up from its 52 week low.

What is Zymeworks Inc's market capitalisation today?

Zymeworks Inc market capitalisation is $0.00T as on .

How to invest in Zymeworks Inc Stock (ZYME) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zymeworks Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zymeworks Inc Shares that will get you 0.0936 shares as per Zymeworks Inc share price of $16.02 per share as on September 16, 2025 at 7:42 pm IST.

What is the minimum amount required to buy Zymeworks Inc Stock (ZYME) from India?

Indian investors can start investing in Zymeworks Inc (ZYME) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Zymeworks Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Zymeworks Inc share’s latest price of $16.02 as on September 16, 2025 at 7:42 pm IST, you will get 0.6242 shares of Zymeworks Inc. Learn more about fractional shares .